News & Blog
Sort by :
Tumor Tip of the Week-03-29-2024 SSDI LN Status: Para-aortic
03-29-2024 SSDI LN Status: Para-aortic Scenario: 5/20/2023 Cervix Biopsy-Invasive Adenocarcinoma, p16 positive. 6/1/2023 PET/CT-No hypermetabolic LAD in chest, abd, or pelvis. Mild hypermetabolic activity present
-
Omega Healthcare
-
29 March
Tumor Tip of the Week 03-22-2024 Definitive Statement of Diagnosis
03-22-2024 Definitive Statement of Diagnosis Scenario: 3/1/2024 CT Abdomen/Pelvis-8 cm solid mass in the right kidney with renal vein invasion. Multiple osseous metastases of the
-
Omega Healthcare
-
21 March
Tumor Tip of the Week 03-15-2024 Melanoma pT1 cN0
03-15-2024 Melanoma pT1 cN0 Scenario: [Physical exam showed no lymphadenopathy], patient dx on Shave biopsy, went on to have Wide excision Snip from Path Report
-
Omega Healthcare
-
15 March
Tumor Tip of the Week-03-08-2024 Kidney Pathologic Stage
Scenario: Renal US: Large left upper pole renal mass measuring up to 8.1 cm. This is considered renal cell carcinoma until proven otherwise. CT Ab/Pelvis:8
-
Omega Healthcare
-
11 March
Tumor Tip of the Week-03-01-2024 HPV Associated Histology
Scenario: 2024 Biopsy Cervix +Squamous cell carcinoma, p16+ Question: How would you assign histology? 8070 Squamous cell carcinoma 8085 Squamous cell carcinoma, HPV Associated Answer:
-
Omega Healthcare
-
04 March
Tumor Tip of the Week-02-23-2024 [Cholangiocarcinoma Tip of the week-revised] see new instructions-Solid Tumor Rules-Other -Table 9a
Scenario: 1-2023 Bx Liver+ Adenocarcinoma Oncologist/GI Multidisciplinary Conference Stage IV (cT2N1M1) intrahepatic cholangiocarcinoma with pulmonary metastases, regional lymphadenopathy, and multifocal hepatic involvement Question: How should
-
Omega Healthcare
-
26 February